Growth Metrics

Ptc Therapeutics (PTCT) Current Taxes (2019 - 2025)

Historic Current Taxes for Ptc Therapeutics (PTCT) over the last 7 years, with Q3 2025 value amounting to $2.9 million.

  • Ptc Therapeutics' Current Taxes fell 5131.4% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 5131.4%. This contributed to the annual value of $4.7 million for FY2024, which is N/A changed from last year.
  • Per Ptc Therapeutics' latest filing, its Current Taxes stood at $2.9 million for Q3 2025, which was down 5131.4% from $39.9 million recorded in Q2 2025.
  • Ptc Therapeutics' Current Taxes' 5-year high stood at $64.6 million during Q1 2025, with a 5-year trough of $618000.0 in Q2 2021.
  • In the last 5 years, Ptc Therapeutics' Current Taxes had a median value of $4.6 million in 2022 and averaged $10.4 million.
  • As far as peak fluctuations go, Ptc Therapeutics' Current Taxes crashed by 7017.38% in 2021, and later surged by 342547.74% in 2025.
  • Over the past 5 years, Ptc Therapeutics' Current Taxes (Quarter) stood at $1.3 million in 2021, then soared by 266.12% to $4.7 million in 2022, then tumbled by 40.11% to $2.8 million in 2023, then surged by 66.58% to $4.7 million in 2024, then tumbled by 37.74% to $2.9 million in 2025.
  • Its Current Taxes was $2.9 million in Q3 2025, compared to $39.9 million in Q2 2025 and $64.6 million in Q1 2025.